{"id":"https://openalex.org/W2158985275","doi":"https://doi.org/10.1185/030079906x100212","title":"Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study","display_name":"Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study","publication_year":2006,"publication_date":"2006-03-23","ids":{"openalex":"https://openalex.org/W2158985275","doi":"https://doi.org/10.1185/030079906x100212","mag":"2158985275","pmid":"https://pubmed.ncbi.nlm.nih.gov/16709303"},"language":"en","primary_location":{"id":"doi:10.1185/030079906x100212","doi":"https://doi.org/10.1185/030079906x100212","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079906x100212","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004441009","display_name":"Mikael Lundborg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115446","display_name":"Healthcare in Sweden","ror":"https://ror.org/036nj8c41","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210115446"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mikael Lundborg","raw_affiliation_strings":["Primary Health Care Centre, Byske, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Primary Health Care Centre, Byske, Sweden","institution_ids":["https://openalex.org/I4210115446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084264591","display_name":"S\u00f8ren Wille","orcid":"https://orcid.org/0000-0002-0017-5922","observed_orcids":["https://orcid.org/0000-0002-0017-5922"]},"institutions":[{"id":"https://openalex.org/I4210132623","display_name":"Helsingborgs lasarett","ror":"https://ror.org/03am3jt82","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I4210132623"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"S\u00f6ren Wille","raw_affiliation_strings":["Paediatric Department, Helsingborg Hospital, Helsingborg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paediatric Department, Helsingborg Hospital, Helsingborg, Sweden","institution_ids":["https://openalex.org/I4210132623"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052171516","display_name":"Leif Hilding Bjermer","orcid":"https://orcid.org/0000-0002-3441-8099","observed_orcids":["https://orcid.org/0000-0002-3441-8099"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leif Bjermer","raw_affiliation_strings":["Lung and Allergy Department, University Hospital, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lung and Allergy Department, University Hospital, Lund, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026487328","display_name":"Bj\u00f6rn Tilling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Tilling","raw_affiliation_strings":["\u00c5tvidaberg Primary Health Care Centre, \u00c5tvidaberg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u00c5tvidaberg Primary Health Care Centre, \u00c5tvidaberg, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012721687","display_name":"Michael Lundgren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Lundgren","raw_affiliation_strings":["Kvartersakuten Health Care Centre, Lule\u00c5, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kvartersakuten Health Care Centre, Lule\u00c5, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071730244","display_name":"Gunilla Telg","orcid":"https://orcid.org/0000-0002-1391-7446","observed_orcids":["https://orcid.org/0000-0002-1391-7446"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Gunilla Telg","raw_affiliation_strings":["AstraZeneca Sweden, S\u00f6dert\u00e4lje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Sweden, S\u00f6dert\u00e4lje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111615769","display_name":"Tommy Ekstr\u00f6m","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Tommy Ekstr\u00f6m","raw_affiliation_strings":["AstraZeneca Sweden, S\u00f6dert\u00e4lje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Sweden, S\u00f6dert\u00e4lje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084124050","display_name":"Olof Selroos","orcid":"https://orcid.org/0000-0001-6404-8095","observed_orcids":["https://orcid.org/0000-0001-6404-8095"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Olof Selroos","raw_affiliation_strings":["SEMECO AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SEMECO AB, Lund, Sweden","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5084124050"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.3402,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.96532119,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"5","first_page":"809","last_page":"821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/budesonide-formoterol","display_name":"budesonide/formoterol","score":0.9480000138282776},{"id":"https://openalex.org/keywords/smart","display_name":"SMART","score":0.3140000104904175},{"id":"https://openalex.org/keywords/maintenance-and-reliever-therapy","display_name":"maintenance and reliever therapy","score":0.8360000252723694},{"id":"https://openalex.org/keywords/persistent-asthma","display_name":"persistent asthma","score":0.6579999923706055},{"id":"https://openalex.org/keywords/inhaled-corticosteroids","display_name":"inhaled corticosteroids","score":0.753000020980835},{"id":"https://openalex.org/keywords/long-acting-beta-agonists","display_name":"long-acting beta2-agonists","score":0.9459999799728394},{"id":"https://openalex.org/keywords/formoterol","display_name":"formoterol","score":0.6430000066757202},{"id":"https://openalex.org/keywords/budesonide","display_name":"budesonide","score":0.6499999761581421},{"id":"https://openalex.org/keywords/asthma-control","display_name":"asthma control","score":0.7419999837875366},{"id":"https://openalex.org/keywords/peak-expiratory-flow","display_name":"peak expiratory flow","score":0.9300000071525574},{"id":"https://openalex.org/keywords/treatment-costs","display_name":"treatment costs","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.8859999775886536},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.5130000114440918},{"id":"https://openalex.org/keywords/asthma-exacerbations","display_name":"asthma exacerbations","score":0.6869999766349792},{"id":"https://openalex.org/keywords/asthma-control-questionnaire","display_name":"Asthma Control Questionnaire","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C2779871671","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Formoterol","level":4,"score":0.9826840162277222},{"id":"https://openalex.org/C2776136866","wikidata":"https://www.wikidata.org/wiki/Q422212","display_name":"Budesonide","level":3,"score":0.9378414154052734},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9000281095504761},{"id":"https://openalex.org/C2777450039","wikidata":"https://www.wikidata.org/wiki/Q637247","display_name":"Budesonide/formoterol","level":5,"score":0.8751437067985535},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.5533252358436584},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.5150396823883057},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.47432631254196167},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4394962191581726},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30403321981430054}],"mesh":[{"descriptor_ui":"D000068759","descriptor_name":"Formoterol Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000280","descriptor_name":"Administration, Inhalation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001993","descriptor_name":"Bronchodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004983","descriptor_name":"Ethanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019819","descriptor_name":"Budesonide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1185/030079906x100212","doi":"https://doi.org/10.1185/030079906x100212","is_oa":false,"landing_page_url":"https://doi.org/10.1185/030079906x100212","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:16709303","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16709303","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"},{"id":"pmh:oai:lup.lub.lu.se:481a140e-cf3e-4f54-bae5-a1ac2ddbf913","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/405650","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1473-4877","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W125359851","https://openalex.org/W132708973","https://openalex.org/W1968604022","https://openalex.org/W1983955745","https://openalex.org/W2005819950","https://openalex.org/W2015350577","https://openalex.org/W2019287735","https://openalex.org/W2019665207","https://openalex.org/W2024585538","https://openalex.org/W2043671273","https://openalex.org/W2055566930","https://openalex.org/W2058113770","https://openalex.org/W2059584922","https://openalex.org/W2085294706","https://openalex.org/W2087760311","https://openalex.org/W2099652899","https://openalex.org/W2105665234","https://openalex.org/W2110658984","https://openalex.org/W2111609315","https://openalex.org/W2117904842","https://openalex.org/W2125135853","https://openalex.org/W2143869213","https://openalex.org/W2145018753","https://openalex.org/W2151896929","https://openalex.org/W2157910210","https://openalex.org/W2331287401","https://openalex.org/W2407065660","https://openalex.org/W3142424398"],"related_works":["https://openalex.org/W2091408344","https://openalex.org/W1998073540","https://openalex.org/W2406468650","https://openalex.org/W1974644571","https://openalex.org/W2015008122","https://openalex.org/W2151038720","https://openalex.org/W2090452747","https://openalex.org/W2107614418","https://openalex.org/W2905802935","https://openalex.org/W1929605331"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"efficacy":[3,132],"and":[4,72,142,192,200,236],"cost-effectiveness":[5],"of":[6,33,52,70,131,151,277,330,345],"budesonide/formoterol":[7,34,78,100,278],"(Symbicort)":[8],"maintenance":[9,87,320],"(one":[10],"dose":[11,32,127,317,344,354],"once":[12,83,318],"or":[13,64,84,95,99,170],"twice":[14,85,105],"daily)":[15],"plus":[16,88,107],"additional":[17,89],"doses":[18,90],"as":[19,37,111],"needed":[20,38,112],"(Symbicort":[21],"Maintenance":[22],"And":[23],"Reliever":[24],"Therapy,":[25],"SMART)":[26,324],"compared":[27,220,254,300],"with":[28,35,41,221,255,266,296,308,339,357],"a":[29,68,73,213,309,327,342],"higher":[30,177],"fixed":[31],"formoterol":[36,108],"in":[39,136,167,178,216,250,282,311,326,355],"patients":[40,54,152,356],"persistent":[42,359],"asthma.":[43,360],"STUDY":[44],"DESIGN":[45],"AND":[46],"METHODS:":[47],"6-month,":[48],"open,":[49],"randomised":[50],"study":[51],"465":[53],"either":[55],"not":[56],"well":[57,65],"controlled":[58,66,218],"on":[59,67],"an":[60,124],"inhaled":[61],"corticosteroid":[62],"(ICS),":[63],"combination":[69],"ICS":[71],"long-acting":[74],"beta(2)-agonist":[75],"(LABA).":[76],"TREATMENTS:":[77],"160/4.5":[79,101],"microg,":[80],"one":[81,316],"inhalation,":[82],"daily":[86,106,319,343],"as-needed":[91],"(1":[92,322],"x":[93,97,114,181,190,194,209,233,239,258,269,298,303,323],"SMART":[94,191,195,210,234,252,284,299],"2":[96,115,180,182,193,232,238,240,257,259,268,270,297,302,304],"SMART),":[98],"microg":[102,110,126],"two":[103,223,346],"inhalations":[104,347],"4.5":[109],"(2":[113],"FIX":[116,183,241,260,271,305],"+":[117,184,242,261,272,306],"F).":[118],"Children":[119],"6-11":[120],"years":[121,154],"old":[122],"used":[123],"80/4.5":[125],"strength.":[128],"Primary":[129],"variables":[130],"were":[133,165,247],"the":[134,137,163,179,188,222,231,237,251,256,267,275,283,351],"changes":[135],"Asthma":[138],"Control":[139],"Questionnaire":[140],"(ACQ(5))":[141],"morning":[143],"peak":[144],"expiratory":[145],"flow":[146],"(PEF).":[147],"RESULTS:":[148],"Mean":[149],"age":[150],"40":[153],"(range":[155],"6-82":[156],"years);":[157],"53%":[158],"female.":[159],"No":[160,226],"differences":[161],"between":[162,230],"groups":[164,196,253,285],"found":[166],"ACQ(5)":[168,289],"scores":[169],"asthma":[171,217,292,312],"exacerbation":[172],"rates.":[173],"Morning":[174],"PEF":[175],"was":[176,228,279],"F":[185,243,262,273,307],"group":[186,211,235],"vs.":[187],"1":[189,208],"(differences":[197],"13":[198],"L/min":[199],"9":[201],"L/min,":[202],"respectively;":[203],"p":[204],"<":[205],"0.002).":[206],"The":[207,315],"showed":[212],"significant":[214],"decrease":[215],"days":[219,338],"other":[224],"groups.":[225],"difference":[227],"seen":[229],"group.":[244,263],"Treatment":[245],"costs":[246],"significantly":[248],"lower":[249,281],"CONCLUSION:":[264],"Compared":[265],"treatment":[274,321,331],"use":[276],"30-40%":[280],"while":[286],"maintaining":[287],"equal":[288],"scores.":[290],"Daily":[291],"control":[293],"improved":[294],"equally":[295],"to":[301,336,349],"reduction":[310],"medication":[313],"cost.":[314],"resulted":[325],"low":[328],"level":[329],"failure":[332],"(exacerbations)":[333],"but":[334],"led":[335],"more":[337],"symptoms.":[340],"Therefore,":[341],"seems":[348],"be":[350],"lowest":[352],"appropriate":[353],"moderate":[358]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}